BioAffinity Technologies Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 1

BioAffinity Technologies General Information

Description

Developer of cancer diagnostic devices designed to test, detect, and treat cancer cells. The company technology analyzes a person's sputum, or phlegm, to find cancer cells that have sloughed off a lung tumor during collection of the sample, and it focuses on non-invasive, early-stage cancer screening, and diagnosis, enabling medical professionals to detect early-stage lung cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • The University of Texas San Antonio
  • One UTSA Circle
  • San Antonio, TX 78249
  • United States
+1 (210) 000-0000

BioAffinity Technologies Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioAffinity Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Debt - PPP 15-Apr-2020 00.00 Completed
3. Angel (individual) 15-May-2018 000 00.00 Completed Startup
2. Angel (individual) 21-Jul-2017 $4.05M $4.2M 0000 Completed Startup
1. Corporate 09-Mar-2017 $150K $150K Completed Startup
To view BioAffinity Technologies’s complete valuation and funding history, request access »

BioAffinity Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.0 00.0 00 00.0 00
To view BioAffinity Technologies’s complete cap table history, request access »

BioAffinity Technologies Executive Team (5)

Name Title Board Seat Contact Info
Maria Zannes JD Chief Executive Officer, President & Board Member
Michael Edwards Chief Financial Officer & Vice President
Vivienne Rebel Ph.D Chief Medical and Science Officer & Executive Vice President, Research & Development
Steven Cantor Co-Founder
David Elzi Vice President of Research
To view BioAffinity Technologies’s complete executive team members history, request access »

BioAffinity Technologies Board Members (8)

Name Representing Role Since
Barry Frankel BioAffinity Technologies Board Member 000 0000
Gary Rubin BioAffinity Technologies Board Member 000 0000
Maria Zannes JD BioAffinity Technologies Chief Executive Officer, President & Board Member 000 0000
Myron Holubiak Self Board Member 000 0000
Peter Knight JD Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

BioAffinity Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioAffinity Technologies Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
San Antonio Development Corporation Other Minority 000 0000 000000 0
To view BioAffinity Technologies’s complete investors history, request access »